Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sunesis and Biogen Idec collaborate on small molecule oncology products

Sep. 9, 2004

New antitumor conjugates with improved half-life designed at Bracco

Sep. 9, 2004

New porphyrin derivatives and their use in cancer radiotherapy

Sep. 9, 2004

CDB-4124 superior to RU-486 in breast cancer model

Sep. 8, 2004

Enrollment underway in third phase I study of CYC-682

Sep. 8, 2004

Bioxel researchers claim new taxane-carbohydrate conjugates

Sep. 8, 2004

Novel Bcr-Abl kinase inhibitors prepared and tested at Sloan-Kettering

Sep. 8, 2004

BMS patent covers new tyrosine kinase inhibitors for use in cancer therapy

Sep. 8, 2004

Antitumor effects of an oblimersen/docetaxel combination in hormone-refractory prostate cancer

Sep. 8, 2004

Fujisawa claims new HDAC inhibitors for immune disorders, cancer, etc.

Sep. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...